Results 151 to 160 of about 6,317 (201)

Efficacy and Safety of Biologics Targeting Type 2 Inflammation in COPD: A Systematic Review and Network Meta-Analysis. [PDF]

Int J Chron Obstruct Pulmon Dis
Li S, Yi B, Wang H, Xu X, Yu L.
europepmc   +1 more source

Molecular Pathogenesis and Targeted Therapies in Eosinophilic Granulomatosis with Polyangiitis: An Updated Review. [PDF]

Int J Mol Sci
López Paraja M, Starita Fajardo G, Donate Velasco I, Lucena López D, Iranzo Alcolea MP, Lirola Sánchez FJ, Peña Rodriguez M, González García A, Manzano Espinosa L.   +8 more
europepmc   +1 more source

Factors influencing the real-world effectiveness of benralizumab in uncontrolled asthma. [PDF]

Sci Rep
Del Mar Sánchez Suárez M, Martín Roldan A, Rojo-Tolosa S, Jiménez-Morales A, Morales-García C.   +4 more
europepmc   +1 more source

Eosinophilic Myocarditis Treated with IL-5 Blockade: An Integrated Case Report and Literature Review. [PDF]

J Clin Med
Takahashi H, Awaya T, Nagamatsu H, Satake Y, Hirose R, Toba N, Toyama-Kousaka M, Ota S, Morikawa M, Tajiri Y, Agemi Y, Nakano N, Shinkai M.   +12 more
europepmc   +1 more source

Benralizumab in Corticosteroid-Refractory Drug Reaction With Eosinophilia and Systemic Symptoms: A Case Report. [PDF]

Cureus
Ross KR, Horesh E, Fang MM, Keller JJ.
europepmc   +1 more source

Benralizumab: from tissue distribution to eosinophilic cytotoxicity up to potential immunoregulation [PDF]

Vultaggio, Alessandra
core  

Benralizumab for asthma.

Australian prescriber
openaire   +1 more source